Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
22 Juillet 2024 - 11:00AM
Business Wire
Bringing experience from Novo Nordisk and Teva
Pharmaceutical Industries, Schultz joins the Hims & Hers Board
of Directors to help the company increase access to health and
wellness solutions
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS),
the leading health and wellness platform, today announced the
appointment of Kåre Schultz to the company’s Board of
Directors.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240722754740/en/
Bringing experience from Novo Nordisk and
Teva Pharmaceutical Industries, Schultz joins the Hims & Hers
Board of Directors to help the company increase access to health
and wellness solutions. (Photo: Business Wire)
Kåre Schultz brings a unique global perspective on the
healthcare and pharmaceutical industries from his decades of
leadership experience at several international organizations,
including Teva Pharmaceutical Industries, Lundbeck, and Novo
Nordisk. Mr. Schultz spent over 25 years at Novo Nordisk, where he
served in many capacities, most notably as President and COO as the
company established itself as a leading company in diabetes care.
As CEO of Teva Pharmaceutical Industries, Mr. Schultz streamlined
operations to focus the company on its core strengths in generics
and specialty medicines. Mr. Schultz also served as CEO of
Lundbeck, where he helped position the company as a leader in the
pharmaceutical industry.
“We are in a transformative moment for healthcare with the
opportunity to make life-changing treatments accessible to all who
need it. Kåre’s experience gives us an incredible wealth of
expertise as we bring together the most valuable elements of
clinical excellence, healthcare, and technology to redefine health
and wellness for our customers,” said Andrew Dudum, CEO and
co-founder of Hims & Hers. “We’re honored to have Kåre join us
to share his perspective and leadership as we continue to serve
more customers across our platform.”
“Hims & Hers is on a trajectory to upend the healthcare
industry,” said Kåre Schultz. “In my long career in the
pharmaceutical industry, this is the first company I have seen that
is leveraging today’s modern tools to truly break down barriers and
change the status quo of how people access the health solutions
they need to live their fullest lives. I’m thrilled to be a part of
this journey.”
Mr. Schultz joins leaders from across industries on the Hims
& Hers Board of Directors including: former CEO of the
Cleveland Clinic, Dr. Toby Cosgrove; tech industry leader,
Christopher Payne; US regulatory and foreign policy expert, Anja
Manuel; former Chief Medical Officer of Walgreens and current Chief
Medical Officer of Hims & Hers, Patrick Carroll; former CFO of
Netflix, David Wells; consumer retail expert, Christiane Pendarvis;
and former Nike and Sony marketing executive, Andrea Perez.
About Hims & Hers Health, Inc
Hims & Hers is the leading health and wellness platform on a
mission to help the world feel great through the power of better
health. We believe how you feel in your body and mind transforms
how you show up in life. That’s why we’re building a future where
nothing stands in the way of harnessing this power. Hims & Hers
normalizes health & wellness challenges—and innovates on their
solutions—to make feeling happy and healthy easy to achieve. No two
people are the same, so the company provides access to personalized
care designed for results. For more information, please visit
www.hims.com and www.forhers.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240722754740/en/
Press Contact Abby Reisinger press@forhims.com
Hims and Hers Health (NYSE:HIMS)
Graphique Historique de l'Action
De Juil 2024 à Juil 2024
Hims and Hers Health (NYSE:HIMS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024